Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study.

Simona GuerzoniFlavia Lo CastroDaria BroviaCarlo BaraldiLuca Pani

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

The risk of developing hypertension during a treatment with anti-calcitonin gene-related peptide monoclonal antibodies seems low. Anyway, patients with a pre-existing hypertension should be cautiously monitored because they are more likely to develop hypertension.

Keyphrases

blood pressure
gene expression
dna methylation
copy number
replacement therapy
smoking cessation